Frits van Rhee, M.D., Ph.D., MRCP, FRCPath
Frits van Rhee, M.D., Ph.D., MRCP, FRCPath
Professor of Medicine
Interim Director of Myeloma Clinical Affairs

Dr. van Rhee is a leading expert in multiple myeloma and Castleman Disease with a research focus in immunotherapy. Profile

Faith Davies, M.D., MRCP, MRCPath, FRCPath
Faith Davies, M.D., MRCP, MRCPath, FRCPath
Professor of Medicine
Director of Myeloma Developmental Therapeutics and Phase I Clinical Trials Program

Dr. Davies is recognized internationally for her expertise in the treatment and research of multiple myeloma and related plasma cell disorders. Her research focuses on innovative targeted molecular therapies, phase 1 clinical trials, and relapsed and refractory multiple myeloma.  Profile

Maurizio Zangari, M.D.

Maurizio Zangari, M.D.
Professor of Medicine
Director of Myeloma Bone Disease Research

Dr. Zangari is a leading expert in multiple myeloma and other hematological malignancies. His research focuses on the clinical and preclinical aspects of bone disease.  Profile

Sharmilan Thanendrarajan, M.D.

Sharmilan Thanendrarajan, M.D.
Assistant Professor of Medicine

Dr. Thanendrarajan is a board-certified hematologist oncologist who specializes in the treatment of newly diagnosed and relapsed/refractory multiple myeloma patients. Profile

Carolina Schinke, M.D.

Carolina Schinke, M.D.
Assistant Professor

Dr. Schinke completed advanced training in Hematology/Oncology at Montefiore Medical Center in New York City. Profile